CD40LG and leprosy: The observed seroprevalence was similar to that found among non-cases (20.8%), which may be attributed to the clinical forms presented by the patients (borderline and primary neural leprosy), which are further from the lepromatous pole, known to be related to high levels of anti-PGL-I IgM antibodies due to the predominance of the humoral immune response.